Acinetobacter baumannii and Pseudomonas aeruginosa are among the most prevalent pathogens causing a wide range of serious infections in hospitalized patients and contaminating intensive care units and inanimate surfaces. The purpose of this study was to investigate the mechanism of carbapenem resistance in clinical and hospital environmental isolates of A. baumannii and P. aeruginosa recovered from a Libyan hospital. From a total of 82 Gram-negative bacteria, 8 isolates of A. baumannii and 3 isolates of P. aeruginosa exhibited resistance to imipenem with minimum inhibitory concentrations ranging from 16 to >32 μg/mL. Five isolates of A. baumannii harbored blaOXA-23 gene, from which three isolates were collected from patients and two from hospital environment. Only one isolate harbored blaNDM-1 gene, which was responsible for carbapenem resistance in A. baumannii. The OprD gene seems to be disturbed by an insertion sequence (IS) in two isolates and affected by polymorphism in one isolate. Pulsed-field gel electrophoresis results showed high genetic diversity among carbapenemase producing A. baumannii. This study highlights the dissemination of blaOXA-23 and blaNDM-1 genes in a Libyan setting. Therefore, infection prevention and control practices, antimicrobial stewardship initiatives, and antimicrobial resistance surveillance systems should be implemented to prevent the wide spread of antimicrobial resistance.
Get full access to this article
View all access options for this article.
References
1.
CerceoE., DeitelzweigS.B, ShermanB.M, and AminA.N.. 2016. Multidrug-resistant gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging treatment options. Microb. Drug Resist. 22:412–431.
2.
TianL., TanR., ChenY., SunJ., LiuJ., and QuH.. 2016. Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality. Antimicrob. Resist. Infect. Control, 5:48.
3.
DieneS.M., and RolainJ.M.. 2014. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 20:831–838.
4.
DijkshoornL., NemecA., and SeifertH.. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939–951.
5.
KilicA., LiH., MellmannA., et al.2008. Acinetobacter septicus sp. nov. association with a nosocomial outbreak of bacteremia in a neonatal intensive care unit. J. Clin. Microbiol. 46:902–908.
6.
WendtC., DietzeB., DietzE., and RüdenH.. 1997. Survival of Acinetobacter baumannii on dry surfaces. J. Clin. Microbiol. 35:1394–1397.
7.
HigginsP.G., DammhaynC., HackelM., and SeifertH.. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65:233–238.
8.
UwingabiyeJ., FrikhM., LemnouerA., et al.2016. Acinetobacter infections prevalence and frequency of the antibiotics resistance: comparative study of intensive care units versus other hospital units. Pan. Afr. Med. J. 23:191.
9.
JohnsonA.P., and WoodfordN.. 2013. Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J. Med. Microbiol. 62,(Pt 4)::499–513.
10.
Da SilvaG., and DominguesS.. 2016. Insights on the horizontal gene transfer of carbapenemase determinants in the opportunistic pathogen Acinetobacter baumannii. Microorganisms, 4:29.
11.
BalasubramanianD., SchneperL., KumariH., and MatheeK.A.. 2013. Dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 41:1–20.
12.
MeletisG., ExindariM., VavatsiN., SofianouD., and DizaE.. 2012. Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. Hippokratia, 16:303–307.
13.
KöhlerT., Michea-HamzehpourM., EppS.F, and PechereJ.C.. 1999. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob. Agents Chemother. 43:424–427.
14.
CastanheiraM., DeshpandeL.M, CostelloA., DaviesT.A, and JonesR.N.. 2014. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009–11 in 14 European and Mediterranean countries. J. Antimicrob. Chemother. 69:1804–1814.
15.
RieraE., CabotG., MuletX., et al.2011. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J. Antimicrob. Chemother. 66:2022–2027.
16.
SefraouiI., BerrazegM., DrissiM., and RolainJ.M.. 2014. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012. Microb. Drug Resist. 20:156–161.
17.
Al BayssariC., DieneS.M, LoucifL., et al.2014. Emergence of VIM-2 and IMP-15 carbapenemases and inactivation of oprD gene in carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Lebanon. Antimicrob. Agents Chemother. 58:4966–4970.
18.
SeifertH., DolzaniL., BressanR., et al.2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43:4328–4335.
19.
DurmazR., OtluB., KoksalF., et al.2009. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn. J. Infect. Dis. 62:372–377.
20.
TenoverF.C., ArbeitR.D, GoeringR.V, et al.1995. Interpreting chromosomal DNA restriction patterns produced by pulsed- field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233–2239.
21.
Bergmans, D.C.J.J., BontenM.J.M, Van TielF.H, et al.1998. Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit. Thorax, 53:1053–1058.
22.
MartinsH.S.I., BomfimM.R.Q, FrançaR.O, et al.2014. Resistance markers and genetic diversity in Acinetobacter baumannii strains recovered from nosocomial bloodstream infections. Int. J. Environ. Res. Public Health, 11:1465–1478.
23.
GniadekT.J., CarrollK.C, and SimnerP.J.. 2016. Carbapenem-resistant non-glucose-fermenting gram-negative bacilli: the missing piece to the puzzle. J. Clin. Microbiol. 54:1700–1710.
24.
RamoulA., LoucifL., BakourS., AmiriS., DekhilM., and RolainJ.M.. 2016. Co-occurrence of blaNDM-1 with blaOXA-23 or blaOXA-58 in clinical multidrug-resistant Acinetobacter baumannii isolates in Algeria. J. Glob. Antimicrob. Resist. 6:136–141.
25.
MathlouthiN., AreigZ., Al BayssariC., et al.2015. Emergence of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates collected from some Libyan hospitals. Microb. Drug Resist. 21:335–341.
26.
MathlouthiN., El SalabiA.A, Ben Jomàa-JemiliM., BakourS., et al.2016. Early detection of metallo-β-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals. Int. J. Antimicrob. Agents, 48:46–50.
27.
Charfi-KessisK., MansourW., Ben Haj KhalifaA., et al.2014. Multidrug-resistant Acinetobacter baumannii strains carrying the blaOXA-23 and the blaGES-11 genes in a neonatology center in Tunisia. Microb. Pathog. 74:20–24.
28.
Ben CheikhH., DominguesS., SilveiraE., et al. 2018. Molecular characterization of carbapenemases of clinical Acinetobacter baumannii-calcoaceticus complex isolates from a University Hospital in Tunisia. 3 Biotech 8:297.
29.
DziriO., Andrea AlonsoC., DziriR., et al.2018. Metallo-β-lactamases and class D carbapenemases in South-East of Tunisia: implication of mobile genetic elements in their dissemination. Int. J. Antimicrob. Agents, 52:871–877.
30.
Da SilvaK.E., MacielW.G, CrodaJ., et al.2018. A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit. PLoS One, 13:e0209367.
31.
MaamarE., AlonsoC.A, FerjaniS., et al.2018. NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia. Int. J. Antimicrob. Agents, 52:910–915.
32.
DancerS.J., CoyneM., RobertsonC., ThomsonA., GuleriA., and AlcockS.. 2006. Antibiotic use is associated with resistance of environmental organisms in a teaching hospital. J. Hosp. Infect. 62:200–206.
33.
KirkgözE., and ZerY.. 2014. Clonal comparison of Acinetobacter strains isolated from intensive care patients and the intensive care unit environment. Turkish J. Med. Sci. 44:643–648.
34.
ObeidatN., JawdatF., Al-BakriA.G, and ShehabiA.A.. 2014. Major biologic characteristics of Acinetobacter baumannii isolates from hospital environmental and patients' respiratory tract sources. Am. J. Infect. Control, 42:401–404.
35.
MugnierP.D., PoirelL., NaasT., and NordmannP.. 2010. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16:35–40.
36.
HammamiS., DahdehC., MamloukK., et al.2017. Rectal carriage of extended-spectrum beta-lactamase and carbapenemase producing gram-negative bacilli in intensive care units in Tunisia. Microb. Drug Resist. 23:695–702.
37.
ElramalliA., AlmshawtN., and AhmedM.O.. 2017. Current problematic and emergence of carbapenemase-producing bacteria: a brief report from a libyan hospital. Pan. Afr. Med. J. 26:1–5.
38.
HammamiS., Boutiba-Ben BoubakerI., GhozziR., SaidaniM., AmineS., and Ben RedjebS.. 2011. Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit. Diagn. Pathol. 6:106.
39.
BellésA., BuenoJ., Rojo-BezaresB., et al.2018. Characterisation of VIM-2-producing Pseudomonas aeruginosa isolates from lower tract respiratory infections in a Spanish hospital. Eur. J. Clin. Microbiol. Infect. Dis. 37:1847–1856.
40.
MeletisG., VavatsiN., ExindariM., and ProtonotariouE.. 2014. Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure. Eur. J. Clin. Microbiol. Infect. Dis. 33:253–258.
41.
EdalucciE., SpinelliR., DolzaniL., et al.2008. Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa. Clin. Microbiol. Infect. 14:88–90.
42.
BelottiP.T., ThabetL., LaffargueA., et al.2015. Description of an original integron encompassing blaVIM-2, qnrVC1 and genes encoding bacterial group II intron proteins in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 70:2237–2240.
43.
TouatiM., DieneS.M, DekhilM., DjahoudiA., RacheracheA., and RolainJ.M.. 2013. Dissemination of a class i integron carrying VIM-2 carbapenemase in Pseudomonas aeruginosa clinical isolates from a hospital intensive care unit in annaba Algeria. Antimicrob. Agents Chemother. 57:2426–2427.
44.
MarouiI., BarguiguaA., AboulkacemA., et al.2016. First report of VIM-2 metallo-β-lactamases producing Pseudomonas aeruginosa isolates in Morocco. J. Infect. Chemother. 22:127–132.
45.
MansourW., PoirelL., BettaiebD., and BouallegueO.. 2009. Metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia. Diagn. Microbiol. Infect. Dis. 64:458–461.
46.
EstepaV., Rojo-BezaresB., Azcona-GutiérrezJ.M, OlarteI., TorresC., and SáenzY.. 2017. Characterisation of carbapenem-resistance mechanisms in clinical Pseudomonas aeruginosa isolates recovered in a Spanish hospital. Enferm. Infecc. Microbiol. Clin. 35:141–147.
47.
EvansJ.C., and SegalH.. 2007. A novel insertion sequence, ISPA26, in oprD of Pseudomonas aeruginosa is associated with carbapenem resistance. Antimicrob. Agents Chemother. 51:3776–3777.
48.
GutiérrezO., JuanC., CercenadoE., et al.2007. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother. 51:4329–4335.
49.
FowlerR.C., and HansonN.D.. 2014. Emergence of carbapenem resistance due to the novel insertion sequence ISPa8 in Pseudomonas aeruginosa. PLoS One, 9:e91299.
50.
DieneS.M., L'hommeT., BelluloS., et al.2013. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France. Int. J. Antimicrob. Agents, 42:268–271.
51.
RakaL., KalenćS., BosnjakZ., et al.2009. Molecular epidemiology of Acinetobacter baumannii in Central Intensive Care Unit in Kosova teaching hospital. Brazilian J. Infect. Dis. 13:408–413.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
